Sam Klempner, Associate Professor at Harvard Medical School, shared a post on X:
“Now out online in Cancer Cell. Fun writing this with Raghav Sundar and talented student Luke Tillman and other.
Reimagining HER2 therapy: Bridging oncogene addiction and immune modulation: Cancer Cell”
Title: Reimagining HER2 therapy: Bridging oncogene addiction and immune modulation
Authors: Luke Tillman, Lajos Pusztai, Seth A. Wander, Raghav Sundar, Samuel J. Klempner
Other articles featuring Dr. Klempner on OncoDaily.